User:Mr. Ibrahem/Ceritinib

Ceritinib, sold under the brand name Zykadia among others, is a medication used to treat non-small cell lung cancer (NSCLC). Specifically it is used for advanced disease that is anaplastic lymphoma kinase (ALK) positive. It is taken by mouth.

Common side effects include diarrhea, nausea, tiredness, liver problems, weight loss, rash, kidney problems, and low red blood cells. Other side effects may include high blood sugar, pneumonitis, QT prolongation, and pancreatitis. Use in pregnancy may harm the baby. It is a tyrosine kinase inhibitor, specifically a ALK inhibitor.

Ceritinib was approved for medical use in the United States in 2014 and Europe in 2015. In the United Kingdom 4 weeks of treatment costs the NHS about £2,800 as of 2021. This amount in the United States is about 10,400 USD.